Qualification of a surrogate matrix-based absolute quantification method for amyloid-β₄₂ in human cerebrospinal fluid using 2D UPLC-tandem mass spectrometry

Qualification of a surrogate matrix-based absolute quantification method for amyloid-β₄₂ in human cerebrospinal fluid using 2D UPLC-tandem mass spectrometry

Item
http://www.wikidata.org/entity/Q34157882
Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014Discovery and Current Status of Evaluation System of Bioavailability and Related Pharmaceutical Technologies for Traditional Chinese Medicines--Flos Lonicerae Japonicae--Fructus Forsythiae Herb Couples as an ExampleCerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement.Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's diseaseEndpoints for Pre-Dementia AD Trials: A Report from the EU/US/CTAD Task Force.Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer's Disease.The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans.Mass-Spectrometry-Based Method To Quantify in Parallel Tau and Amyloid β 1-42 in CSF for the Diagnosis of Alzheimer's Disease.Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer's Disease.Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.
P2860

Qualification of a surrogate matrix-based absolute quantification method for amyloid-β₄₂ in human cerebrospinal fluid using 2D UPLC-tandem mass spectrometry

Item
http://www.wikidata.org/entity/Q34157882
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Qualification of a surrogate m ...... UPLC-tandem mass spectrometry
@ast
Qualification of a surrogate m ...... UPLC-tandem mass spectrometry
@en
Qualification of a surrogate m ...... UPLC-tandem mass spectrometry
@nl
type
label
Qualification of a surrogate m ...... UPLC-tandem mass spectrometry
@ast
Qualification of a surrogate m ...... UPLC-tandem mass spectrometry
@en
Qualification of a surrogate m ...... UPLC-tandem mass spectrometry
@nl
prefLabel
Qualification of a surrogate m ...... UPLC-tandem mass spectrometry
@ast
Qualification of a surrogate m ...... UPLC-tandem mass spectrometry
@en
Qualification of a surrogate m ...... UPLC-tandem mass spectrometry
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Qualification of a surrogate m ...... UPLC-tandem mass spectrometry
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932